Perrigo CEO says no easy path for Mylan to acquire company

(Reuters) – Perrigo Co Plc on Wednesday made a fresh case for rejecting a $34 billion offer from generic drugmaker Mylan NV and said Mylan’s recent share price plunge reinforces Perrigo’s intention to remain independent.